Method for diagnosing Lyme disease using a cellular immunological test
AssigneeStichting Katholieke Universiteit
InventorsLeonardus Antonius Bernardus Joosten, Mihai Gheorghe Netea, Johannes Willem Maarten van der Meer, Bart Julian Kullberg
Life of this patent
Estimating the term…
Abstract
The present invention relates to a method for diagnosing Lyme disease in a subject, the method comprising the steps of: (a) obtaining a sample from said subject, (b) contacting said sample with a source of Borrelia antigens and (c) determining the expression level of a pro-inflammatory cytokine in said sample at the end of step (b).
Claims31
A method for diagnosing Lyme disease in a subject, the method comprising the steps of:
- (a) contacting a sample obtained from said subject with a source of Borellia antigen from a species of Borellia selected from the group consisting of B. burgdorferi, B. garinii, B. afzelii and combinations thereof, wherein said sample comprises peripheral blood mononuclear cells (PBMC);
- (b) determining a protein expression level of IL-1β in said sample at the end of step (a);
- and
- (c) diagnosing Lyme disease in said subject when a detectable expression level or an increase of the expression level of IL-1β is determined in step (b).
A method for diagnosing Lyme disease in a subject, the method comprising the steps of:
- (a) contacting a sample obtained from said subject with a source of Borellia antigen from a species of Borellia selected from the group consisting of B. burgdorferi, B. garinii, B. afzelii and combinations thereof, wherein said sample comprises peripheral blood mononuclear cells (PBMC);
- (b) determining protein expression of IL-1β in said sample at the end of step (a);
- and
- (c) diagnosing Lyme disease in said subject when detectable expression of IL-1β is determined in step (b).
Dependencies are inferred from the claim text.